Patent Assignment
Reel/Frame 051377/0958
Security Interest
Recorded: 2019-12-19
Pages: 15
Assignors
CURRAX PHARMACEUTICALS LLC
Executed: 2019-12-13
NALPROPION PHARMACEUTICALS LLC
Executed: 2019-12-13
Assignee
WILMINGTON SAVINGS FUND SOCIETY, FSB
500 DELAWARE AVENUE, WILMINGTON, DELAWARE, 19801
Covered Properties
(74)
Process for Preparing Tannate Tablet, Capsule or Other Solid Dosage Forms
Compositions for Affecting Weight Loss
Process for Preparing Tannate Liquid and Semi-Solid Dosage Forms
Compositions for Affecting Weight Loss
Tannate Compositions, Methods of Making and Methods of Use
Compositions and methods for increasing insulin sensitivity
Sustained Release Formulation of Naltrexone
Methods of Improving the Pharmacokinetics of Doxepin
Methods of Using Low-Dose Doxepin for the Improvement of Sleep
Layered Pharmaceutical Formulations
Hyaluronate Compositions
Phosphate-Binding Chitosan and Uses Thereof
Methods for Administering Weight Loss Medications
Methods of Providing Weight Loss Therapy in Patients with Major Depression
Layered Pharmaceutical Formulations
Methods of Using Low-Dose Doxepin for the Improvement of Sleep
Phosphate-Binding Chitosan and Uses Thereof
Application:
13/544,775 →
Publication:
US 2012/0277183
Methods of Treating Insomnia Using a Combination Therapy of Low-Dose Doxepin and Zolpidem
Methods of Improving the Pharmacokinetics of Doxepin
Doxepin Isomers and Isomeric Mixtures and Methods of Using the Same to Treat Sleep Disorders
Doxepin Trans Isomers and Isomeric Mixtures and Methods of Using the Same to Treat Sleep Disorders
Methods of Using Low-Dose Doxepin for the Improvement of Sleep
Application:
13/764,467 →
Publication:
US 2013/0150434
Phosphate-Binding Magnesium Salts and Uses Thereof
Low-Dose Doxepin Formulations and Methods of Making and Using the Same
Hyaluronate Compositions
Methods for Reducing Binge or Compulsive Eating
Application:
13/991,372 →
Publication:
US 2013/0252995
Ultra Low Dose Doxepin and Methods of Using the Same to Treat Sleep Disorders
Crystal Polymorph of Magnesium Glycinate Dihydrate and Process for Its Preparation
Methods for Administering Weight Loss Medications
Compositions and Methods for Weight Loss in at Risk Patient Populations
Patent:
8,969,371 →
Application:
14/322,810 →
Compositions and Methods for Increasing Insulin Sensitivity
Methods of Treating Overweight and Obesity
Sustained Release Formulation of Naltrexone
Compositions and Methods for Weight Loss in at Risk Patient Populations
Low-Dose Doxepin for Treatment of Sleep Disorders in Elderly Patients
Hyaluronate Compositions
Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep
Compositions and Methods for Weight Loss in at Risk Patient Populations
Layered Pharmaceutical Formulations
Application:
14/988,556 →
Publication:
US 2016/0338965
Methods of Providing Weight Loss Therapy in Patients with Major Depression
Compositions and Methods for Reducing Major Adverse Cardiovascular Events
Phosphate-Binding Magnesium Salts And Uses Thereof
Crystal Polymorph of Magnesium Glycinate Dihydrate and Process for Its Preparation
Compositions for Affecting Weight Loss
Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
Methods of Using Low-Dose Doxepin for the Improvement of Sleep
Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
Low-Dose Doxepin Formulations and Methods of Making and Using the Same
Compositions and Methods for Reducing Food Cravings
Application:
15/411,585 →
Publication:
US 2017/0312269
Methods of Improving the Pharmacokinetics of Doxepin
Methods for Treating Visceral Fat Conditions
Phosphate-Binding Magnesium Salts And Uses Thereof
Methods of Treating Overweight and Obesity
Compositions and Methods for Weight Loss in at Risk Patient Populations
Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
Methods of Using Low-Dose Doxepin for the Improvement of Sleep
Low-Dose Doxepin Formulations And Methods Of Making And Using The Same
Ultra Low Dose Doxepin and Methods of Using the Same to Treat Sleep Disorders
Hyaluronate Compositions
Application:
15/948,598 →
Publication:
US 2018/0303777
Methods For Administering Weight Loss Medications
Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
Sustained Release Formulation Of Naltrexone
Application:
16/284,453 →
Publication:
US 2019/0183883
Compositions And Methods For Weight Loss In At Risk Patient Populations
Compositions And Methods For Reducing Major Adverse Cardiovascular Events
Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep
Compositions For Affecting Weight Loss
Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
Compositions And Methods For Increasing Insulin Sensitivity
Application:
16/378,177 →
Publication:
US 2019/0231852
Methods For Administering Weight Loss Medications
Application:
16/428,069 →
Publication:
US 2019/0282503
Methods Of Providing Weight Loss Therapy In Patients With Major Depression
Increasing Drug Bioavailability In Naltrexone Therapy
Application:
16/534,509 →
Publication:
US 2019/0358222
Methods of Treating Overweight and Obesity
Low Dose Doxepin Formulations, Including Buccal, Sublingual And Fastmelt Formulations, And Uses Of The Same To Treat Insomnia
Application:
16/686,113 →
Publication:
US 2020/0078295
Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Nov 25, 2009
From: CYPRESS PHARMACEUTICALS, INC.
To: TRUSTMARK NATIONAL BANK
Reel/Frame 023569/0695 →
Security Agreement
May 8, 2012
From: CYPRESS PHARMACEUTICALS, INC.
To: TRUSTMARK NATIONAL BANK
Reel/Frame 028170/0682 →
Assignment of Assignor's Interest
Oct 9, 2012
From: MCKINNEY, ANTHONY; TOLLEFSON, GARY; WEBER, ECKARD; SOLTERO, RICK
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 029121/0736 →
Assignment of Assignor's Interest
Oct 12, 2012
From: LEWIS, ROBERT L.; DAY, CHARLES E.
To: CYPRESS PHARMACEUTICAL, INC.
Reel/Frame 029119/0425 →
Release of Security Interest
Dec 31, 2012
From: TRUSTMARK NATIONAL BANK
To: CYPRESS PHARMACEUTICALS, INC.; HAWTHORN PHARMACEUTICALS, INC.
Reel/Frame 029547/0298 →
Security Agreement
Jan 3, 2013
From: PERNIX THERAPEUTICS, LLC
To: MIDCAP FUNDING V, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 029567/0694 →
Security Agreement
Jan 3, 2013
From: CYPRESS PHARMACEUTICALS, INC.
To: MIDCAP FUNDING V, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 029569/0012 →
Merger
Jul 17, 2013
From: SOMAXON PHARMACEUTICALS, INC.
To: PERNIX SLEEP, INC.
Reel/Frame 030819/0883 →
Patent Transfer and Assignment
Sep 13, 2013
From: MIDCAP FINANCIAL, LLC
To: MIDCAP FUNDING IV, LLC
Reel/Frame 031266/0572 →
Patent Transfer and Assignment
Sep 13, 2013
From: MIDCAP FUNDING V, LLC
To: MIDCAP FINANCIAL, LLC
Reel/Frame 031266/0437 →
Stock Power/Stock Certificates
Jan 17, 2014
From: CYPRESS PHARMACEUTICALS, INC.
To: PERNIX THERAPEUTICS HOLDINGS, INC.
Reel/Frame 032076/0271 →
Merger
Feb 3, 2014
From: PERNIX SLEEP, INC.
To: PERNIX THERAPEUTICS HOLDINGS, INC.
Reel/Frame 032118/0135 →
Merger
Feb 3, 2014
From: SOMAXON PHARMACEUTICALS, INC.
To: PERNIX THERAPEUTICS HOLDINGS, INC.
Reel/Frame 032118/0272 →
Release of Security Interest in Patent Rights Reel/Frame 029567/0694
Feb 24, 2014
From: MIDCAP FUNDING IV, LLC (SUCCESSOR IN INTEREST TO MIDCAP FUNDING V, LLC)
To: PERNIX THERAPEUTICS, LLC
Reel/Frame 032330/0037 →
Release of Security Interest in Patent Rights Reel/Frame 030441/0229
Feb 24, 2014
From: MIDCAP FUNDING IV, LLC (SUCCESSOR IN INTEREST TO MIDCAP FINANCIAL, LLC)
To: PERNIX SLEEP, INC.
Reel/Frame 032330/0023 →
Release of Security Interest in Patent Rights Reel/Frame 029569/0012
Feb 24, 2014
From: MIDCAP FUNDING IV, LLC (SUCCESSOR IN INTEREST TO MIDCAP FUNDING V, LLC)
To: CYPRESS PHARMACEUTICALS, INC.
Reel/Frame 032330/0060 →
Assignment of Assignor's Interest
Mar 18, 2014
From: MCKINNEY, ANTHONY; TOLLEFSON, GARY; WEBER, ECKARD; SOLTERO, RICK
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 032463/0479 →
Assignment of Assignor's Interest
Apr 30, 2014
From: ROGOWSKI, ROBERTA L.; DUBE, SUSAN E.; JOCHELSON, PHILLIP
To: SOMAXON PHARMACEUTICALS, INC.
Reel/Frame 032791/0680 →
Assignment of Assignor's Interest
Aug 21, 2015
From: PERNIX THERAPEUTICS HOLDINGS, INC.
To: PERNIX SLEEP, INC.
Reel/Frame 036387/0667 →
Assignment of Assignor's Interest
Aug 21, 2015
From: PERNIX THERAPEUTICS HOLDINGS, INC.
To: CYPRESS PHARMACEUTICALS, INC.
Reel/Frame 036387/0660 →
Assignment of Assignor's Interest
Dec 18, 2015
From: DUNAYEVICH, EDUARDO; DEWITT (LEGAL REPRESENTATIVE OF GARY TOLLEFSON (DECEASED)), DAVID
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 037334/0490 →
Security Agreement
Mar 21, 2016
From: OREXIGEN THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 038180/0021 →
Assignment of Assignor's Interest
Mar 22, 2017
From: WEBER, ECKARD; COWLEY, MICHAEL ALEXANDER
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041688/0847 →
Assignment of Assignor's Interest
Aug 2, 2018
From: OREXIGEN THERAPEUTICS, INC.
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 046688/0661 →
Security Interest
Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →